Search

Search Constraints

You searched for: Author/Creator Wulffraat, Nico

Search Results

1. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Issue 3 (10th February 2016)

2. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Issue 3 (9th February 2016)

4. A6: Tapering and Withdrawal of Tocilizumab in Patients With Systemic Juvenile Idiopathic Arthritis in Inactive Disease: Results From an Alternative Dosing Regimen in the TENDER Study. Issue 11 (March 2014)

5. A6: Tapering and Withdrawal of Tocilizumab in Patients With Systemic Juvenile Idiopathic Arthritis in Inactive Disease: Results From an Alternative Dosing Regimen in the TENDER Study. Issue Volume 66:Issue(2014)supplement 3 (March 2014)

6. AB1072B THE CONSEQUENCES OF THE PROVISIONAL PAEDIATRIC RHEUMATOLOGY INTERNATIONAL TRIALS ORGANISATION JUVENILE IDIOPATHIC ARTHRITIS CLASSIFICATION CRITERIA. (June 2019)

7. Common Functional Ability Score for Young People With Juvenile Idiopathic Arthritis. Issue 7 (4th June 2021)

8. Consensus-based recommendations for the management of juvenile systemic sclerosis. (4th November 2020)

9. Costs of Hospital‐Associated Care for Patients With Juvenile Idiopathic Arthritis in the Dutch Health Care System. Issue 10 (7th July 2022)

10. Costs of medication use among patients with juvenile idiopathic arthritis in the Dutch healthcare system. (3rd September 2021)